As sites of antigen presentation and lymphocyte activation, TLS facilitate the generation of tumor-specific immune responses and often correlate with increased infiltration of cytotoxic CD8+ T cells into the TME, a key determinant of antitumor activity [6,7,8,9]. The gene discussed is CD8A; the disease is neoplasm.